MoonLake Immunotherapeutics MLTX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $298.49M+9.9% | $334.52M+85.4% | $350.7M-6.7% | $306.7M-10.5% | $271.6M-40.8% | ||
| $59.43M-71.5% | $59.45M-77.8% | $29.74M-74.9% | $118.4M-33.1% | $208.56M+135% | ||
| $1.61M+58.4% | $1.12M+146% | $1.41M+88.4% | $1.34M+45.3% | $1.01M+58.2% | ||
| $396.64M-21.7% | $421.69M-11.1% | $411.22M-19.7% | $455.48M-15.2% | $506.26M-8.5% | ||
| $532K-25.2% | $577K-20.1% | $622K+7.0% | $667K+38.5% | $711K+39.5% | ||
| 6.4%+1.7% | 4.6%-292,199,995% | 4.7%0.0% | 4.7%-0.1% | 4.7%-0.1% | ||
| $1.34M-20.8% | $596K— | $587K— | $1.7M— | $1.7M— | ||
| $3.73M-25.3% | $2.74M-24.8% | $3.12M-47.1% | $4.62M-42.3% | $5M-52.5% | ||
| $400.37M-21.7% | $424.43M-11.2% | $414.34M-20.0% | $460.1M-15.6% | $511.26M-9.4% | ||
| $2.2M-13.5% | $2.32M-80.8% | $4.2M+43.7% | $3.23M+64.6% | $2.54M+111% | ||
| $920K-35.8% | $1.23M-10.1% | $1.5M+3.7% | $1.55M+17.3% | $1.43M+9.8% | ||
| $1.4M-37.5% | $1.09M+70.4% | $1.01M+109% | $836K+35.1% | $2.23M+162% | ||
| $46.11M+92.3% | $45.48M+102% | $48.37M+141% | $27.36M+123% | $23.98M+169% | ||
| $99.02M+35.6% | $74.1M— | $73.74M— | $73.38M— | $73.02M— | ||
| $865K-24.3% | $374K-74.3% | $486K-74.9% | $836K-58.7% | $1.14M-51.6% | ||
| $1.79M-30.7% | $1.61M-43.2% | $1.99M-41.3% | $2.39M-28.6% | $2.57M-29.7% | ||
| $100.24M+34.2% | $74.47M+3,482% | $74.78M+2,742% | $74.79M+2,817% | $74.7M+2,549% | ||
| $146.35M+48.3% | $119.95M+389% | $123.14M+442% | $102.15M+588% | $98.68M+741% | ||
| $786.31M+15.5% | $766.78M+13.2% | $689.11M+2.0% | $683.96M+1.8% | $680.66M+1.6% | ||
| -$532.62M-93.3% | -$462.91M-96.5% | -$400.49M-111% | -$330.76M-114% | -$275.54M-111% | ||
| $322K-86.5% | $604K-87.9% | $278K-90.2% | $520K-84.0% | $2.39M-11.4% | ||
| $254.02M-37.7% | $304.48M-31.9% | $288.91M-40.8% | $353.73M-32.1% | $407.52M-24.9% | ||
| $400.37M-21.7% | $424.43M-11.2% | $414.34M-20.0% | $460.1M-15.6% | $511.26M-9.4% | ||
| $59.07M-71.3% | $59.17M-81.6% | $29.26M-83.3% | $117.66M-49.6% | $205.91M-25.2% | ||
| $59.43M-71.5% | $59.45M-81.8% | $29.74M-83.3% | $118.4M-50.0% | $208.56M-25.0% | ||
| $59.43M-71.5% | $59.45M-77.8% | $29.74M-74.9% | $118.4M-33.1% | $208.56M+135% | ||
| $357.9M— | —— | —— | —— | —— | ||
| $5.76M+92.9% | $4.87M+71.2% | $4.02M+67.1% | $3.41M+103% | $2.99M+99.7% | ||
| $5.76M+92.9% | $4.87M+71.2% | $4.02M+67.1% | $3.41M+103% | $2.99M+99.7% | ||
| $1.34M-20.8% | $596K— | $587K— | $1.7M— | $1.7M— | ||
| $59.07M-71.3% | $59.17M-81.6% | $29.26M-83.3% | $117.66M-49.6% | $205.91M-25.2% | ||
| $1.86M-28.3% | $1.57M-46.4% | $1.91M-41.2% | $2.25M-33.5% | $2.59M-30.0% | ||
| $1.34M-20.8% | $587K— | $587K— | $1.7M— | $1.7M— | ||
| $1.86M-28.3% | $1.57M-46.4% | $1.91M-41.2% | $2.25M-33.5% | $2.59M-30.0% | ||
| $1.34M-20.8% | $596K— | $587K— | $1.7M— | $1.7M— | ||
| $1.86M-28.3% | $1.57M-46.4% | $1.91M-41.2% | $2.25M-33.5% | $2.59M-30.0% | ||
| $1.34M-20.8% | $596K— | $587K— | $1.7M— | $1.7M— | ||
| $2.2M-13.5% | $2.32M-45.1% | $4.2M+43.7% | $3.23M+64.6% | $2.54M+111% | ||
| $1.4M-37.5% | $1.09M+70.4% | $1.01M+109% | $836K+35.1% | $2.23M+162% | ||
| $2.2M-13.5% | $2.32M-45.1% | $4.2M+43.7% | $3.23M+64.6% | $2.54M+111% | ||
| $23.38M+94.7% | $29.55M+229% | $25.28M+136% | $17.08M+232% | $12.01M+245% | ||
| $875K-23.0% | —— | $400K+3.5% | $811K+12.2% | $1.14M+4.9% | ||
| $458K+237% | —— | $147K-88.2% | $147K-87.0% | $136K-88.0% | ||
| $458K+398% | —— | $100K-28.7% | $100K+7.9% | $92K-1.6% | ||
| $458K+237% | —— | $147K-88.2% | $147K-87.0% | $136K-88.0% | ||
| $98K-27.9% | —— | $147K+4.8% | $147K+58.6% | $136K+45.4% | ||
| $487K-59.3% | —— | $1.27M-19.3% | $1.29M-11.1% | $1.2M-17.1% | ||
| $1.92M-28.9% | —— | $2.06M-42.3% | $2.49M-29.9% | $2.7M-31.0% | ||
| $133K+8.1% | —— | $79K-59.8% | $104K-49.8% | $123K-50.3% | ||
| $100M+33.3% | $75M— | $75M— | $75M— | $75M— | ||
| $5.94M+427% | $4.52M— | $1.01M— | $1.07M— | $1.13M— | ||
| $353K-34.1% | $0-100% | $549K-21.0% | $574K+5.9% | $536K+15.8% | ||
| $98K-27.9% | —— | $147K+4.8% | $147K+58.6% | $136K+45.4% | ||
| $98K-27.9% | —— | $147K+4.8% | $147K+58.6% | $136K+45.4% | ||
| $21.81M+107% | $14.69M+21.4% | $21.59M+172% | $8.73M+50.1% | $10.54M+156% | ||
| $100.8M+33.3% | $75.71M+2,576% | $75.73M+2,140% | $75.77M+2,166% | $75.6M+1,964% | ||
| $11.29-73.0% | —— | —— | —— | $41.77— | ||
| $362K-86.3% | $285K-94.7% | $487K-84.9% | $743K-79.1% | $2.65M-8.7% | ||
| $59.07M-71.3% | $59.17M-81.6% | $29.26M-83.3% | $117.66M-49.6% | $205.91M-25.2% | ||
| $363K-56.4% | $430K-26.6% | $418K+18.8% | $386K+90.1% | $833K+129% | ||
| $8.68M+113% | $4.23M+109% | $10.68M+228% | $2.82M+33.2% | $4.07M+460% | ||
| $9.18M+3,472% | $6.62M+47.9% | $4.64M+418% | $917K+11.7% | $257K-71.8% | ||
| $362K-86.3% | $285K-94.7% | $487K-84.9% | $743K-79.1% | $2.65M-8.7% | ||
| $59.07M-71.3% | $59.17M-81.6% | $29.26M-83.3% | $117.66M-49.6% | $205.91M-25.2% | ||
| $59.43M-71.5% | $59.45M-81.8% | $29.74M-83.3% | $118.4M-50.0% | $208.56M-25.0% | ||
| 3,363.9%0.0% | —— | 3,363.9%0.0% | 3,363.9%— | 3,363.9%— | ||
| $350.5M-27.3% | —— | $362.8M-26.3% | $428.1M-18.4% | $482.3M-11.5% | ||
| $4.96M— | $3.62M— | $3.53M— | $3.43M— | —— | ||
| $100M+33.3% | $75M— | $75M— | $75M— | $75M— | ||
| $5.94M— | $4.52M— | —— | —— | —— | ||
| $353K-34.1% | $0-100% | $549K-21.0% | $574K+5.9% | $536K+15.8% | ||
| $1.92M-28.9% | —— | $2.06M-42.3% | $2.49M-29.9% | $2.7M-31.0% | ||
| $0— | —— | —— | —— | —— | ||
| $133K+8.1% | —— | $79K-59.8% | $104K-49.8% | $123K-50.3% | ||
| $2.39M-27.6% | $2.14M-41.2% | $2.53M-33.9% | $2.92M-24.5% | $3.3M-21.6% | ||
| $0.06+36.2% | $0.05-2.1% | $0.050.0% | $0.05-2.1% | $0.05-2.1% | ||
| $32.96M+42.4% | $22.86M-2.4% | $26.71M+67.1% | $26.99M+75.2% | $23.15M+359% | ||
| $551K-29.0% | $886K-20.4% | $1.04M-30.8% | $1.34M-32.6% | $776K+35.0% | ||
| $16.33M+14.2% | $17.36M+22.8% | $17.58M+138% | $17.3M+111% | $14.31M+732% | ||
| $11.29-73.0% | —— | —— | —— | $41.77— | ||
| $14.47M+105% | $3.49M-54.7% | $6.69M+5.3% | $7.02M+63.4% | $7.05M+235% | ||
| $175.7M-14.5% | —— | $191M+31.6% | $223.9M+78.4% | $205.6M+235% | ||
| $875K-23.0% | —— | $400K+3.5% | $811K+12.2% | $1.14M+4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can MoonLake Immunotherapeutics cover its short-term obligations?
- Its current ratio is 8.60 — current assets exceed current liabilities.
- Where does MoonLake Immunotherapeutics's balance sheet data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.